Gene · 4633
Papers3,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human multilineage pro-epicardium/foregut organoids support the development of an epicardium/myocardium organoid. | Nat Commun | 2022 | 36379937 | PubTator, text mining | PubMed |
| CD16+ fibroblasts foster a trastuzumab-refractory microenvironment that is reversed by VAV2 inhibition. | Cancer Cell | 2022 | 36379207 | PubTator, text mining | PubMed |
| Matrix Adhesiveness Regulates Myofibroblast Differentiation from Vocal Fold Fibroblasts in a Bio-orthogonally Cross-linked Hydrogel. | ACS Appl Mater Interfaces | 2022 | 36367478 | PubTator, text mining | PubMed |
| Direct Action of Non-Digestible Oligosaccharides against a Leaky Gut. | Nutrients | 2022 | 36364961 | PubTator, text mining | PubMed |
| Uncovering the Inhibitory Molecular Mechanism of Pomegranate Peel to Urinary Bladder Urothelial Carcinoma Using Proteomics Techniques. | Life (Basel) | 2022 | 36362994 | PubTator, text mining | PubMed |
| Quantitative Proteomics Analysis Reveals That Cyclooxygenase-2 Modulates Mitochondrial Respiratory Chain Complex IV in Cardiomyocytes. | Int J Mol Sci | 2022 | 36362254 | PubTator, text mining | PubMed |
| Serum SELENBP1 and VCL Are Effective Biomarkers for Clinical and Forensic Diagnosis of Coronary Artery Spasm. | Int J Mol Sci | 2022 | 36362053 | PubTator, text mining | PubMed |
| CXC- receptor 2 promotes extracellular matrix production and attenuates migration in peripapillary human scleral fibroblasts under mechanical strain. | J Cell Mol Med | 2022 | 36349481 | PubTator, text mining | PubMed |
| CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia. | Nat Commun | 2022 | 36347876 | PubTator, text mining | PubMed |
| The role of BMP4 in adipose-derived stem cell differentiation: A minireview. | Front Cell Dev Biol | 2022 | 36340030 | PubTator, text mining | PubMed |
| Lamin A/C-dependent chromatin architecture safeguards naïve pluripotency to prevent aberrant cardiovascular cell fate and function. | Nat Commun | 2022 | 36333314 | PubTator, text mining | PubMed |
| Short Sleep Duration and Erectile Dysfunction: A Review of the Literature. | Nat Sci Sleep | 2022 | 36325277 | PubTator, text mining | PubMed |
| Extracellular fluid viscosity enhances cell migration and cancer dissemination. | Nature | 2022 | 36323783 | PubTator, text mining | PubMed |
| Virulence factors released from Porphyromonas gingivalis induce electrophysiological dysfunction in human pluripotent stem cell-derived cardiomyocytes. | J Dent Sci | 2022 | 36299350 | PubTator, text mining | PubMed |
| Small-Molecule RAF265 as an Antiviral Therapy Acts against PEDV Infection. | Viruses | 2022 | 36298816 | PubTator, text mining | PubMed |
| Protein O-GlcNAcylation in Metabolic Modulation of Skeletal Muscle: A Bright but Long Way to Go. | Metabolites | 2022 | 36295790 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes. | Biomolecules | 2022 | 36291626 | PubTator, text mining | PubMed |
| Genetic Variants of CITED2 Gene Promoter in Human Atrial Septal Defects: Case-Control Study and Cellular Functional Verification. | J Cardiovasc Dev Dis | 2022 | 36286273 | PubTator, text mining | PubMed |
| Identifying and Targeting Prediction of the PI3K-AKT Signaling Pathway in Drug-Induced Thrombocytopenia in Infected Patients Receiving Linezolid Therapy: A Network Pharmacology-Based Analysis. | J Healthc Eng | 2022 | 36285187 | PubTator, text mining | PubMed |
| ROCK1/MLC2 inhibition induces decay of viral mRNA in BPXV infected cells. | Sci Rep | 2022 | 36280692 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4633/papers?page=28